The management of retrorectal tumors - a single-center analysis of 21 cases and overview of the literature.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
14 Sep 2024
Historique:
received: 12 05 2024
accepted: 04 09 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Retrorectal tumors are rare and heterogeneous. They are often asymptomatic or present with nonspecific symptoms, making management challenging. This study examines the diagnosis and treatment of retrorectal tumors. Between 2002 and 2022, 21 patients with retrorectal tumors were treated in our department. We analyzed patient characteristics, diagnosis and treatment modalities retrospectively. Additionally, a literature review (2002-2023, "retrorectal tumors" and "presacral tumors", 20 or more cases included) was performed. Of the 21 patients (median age 54 years, 62% female), 17 patients (81%) suffered from benign lesions and 4 (19%) from malignant lesions. Symptoms were mostly nonspecific, with pain being the most common (11/21 (52%)). Diagnosis was incidental in eight cases. Magnetic resonance imaging was performed in 20 (95%) and biopsy was obtained in 10 (48%). Twenty patients underwent surgery, mostly via a posterior approach (14/20 (70%)). At a mean follow-up of 42 months (median 10 months, range 1-166 months), the local recurrence rate was 19%. There was no mortality. Our Pubmed search identified 39 publications. Our data confirms the significant heterogeneity of retrorectal tumors, which poses a challenge to management, especially considering the often nonspecific symptoms. Regarding diagnosis and treatment, our data highlights the importance of MRI and surgical resection. In particular a malignancy rate of almost 20% warrants a surgical resection in case of the findings of a retrorectal tumour. A local recurrence rate of 19% supports the need for follow up.

Identifiants

pubmed: 39276267
doi: 10.1007/s00423-024-03471-0
pii: 10.1007/s00423-024-03471-0
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

279

Informations de copyright

© 2024. The Author(s).

Références

Neale JA (2011) Retrorectal tumors. Clin Colon Rectal Surg, 24:149 – 60. https://doi.org/10.1055/s-0031-1285999
Oguz A, Böyük A, Turkoglu A et al (2015) Retrorectal Tumors in adults: a 10-Year retrospective study. Int Surg 100:1177–1184. https://doi.org/10.9738/INTSURG-D-15-00068.1
doi: 10.9738/INTSURG-D-15-00068.1 pubmed: 26595490
Jao SW, Beart RW Jr, Spencer RJ, Reiman HM, Ilstrup DM (1985) Retrorectal tumors. Mayo Clinic experience, 1960–1979. Dis Colon Rectum 28:644–652. https://doi.org/10.1007/BF02553440
doi: 10.1007/BF02553440 pubmed: 2996861
Strupas K, Poskus E, Ambrazevicius M (2011) Retrorectal tumours: literature review and vilnius university hospital santariskiu klinikos experience of 14 cases. Eur J Med Res 16:231–236. https://doi.org/10.1186/2047-783x-16-5-231
doi: 10.1186/2047-783x-16-5-231 pubmed: 21719397 pmcid: 3352196
García-Armengol J, García-Botello S, Martinez-Soriano F, Roig JV, Lledó S (2008) Review of the anatomic concepts in relation to the retrorectal space and endopelvic fascia: Waldeyer’s fascia and the rectosacral fascia. Colorectal Dis 10:298–302. https://doi.org/10.1111/j.1463-1318.2007.01472.x
doi: 10.1111/j.1463-1318.2007.01472.x pubmed: 18257849
Messick CA (2018) Presacral (Retrorectal) tumors: optimizing the management strategy. Dis Colon Rectum 61:151–153. https://doi.org/10.1097/DCR.0000000000001021
doi: 10.1097/DCR.0000000000001021 pubmed: 29337767
Uhlig BE, Johnson RL (1975) Presacral tumors and cysts in adults. Dis Colon Rectum 18:581–589. https://doi.org/10.1007/BF02587141
doi: 10.1007/BF02587141 pubmed: 1181162
Glasgow SC, Dietz DW (2006) Retrorectal tumors. Clin Colon Rectal Surg 19:61–68. https://doi.org/10.1055/s-2006-942346
doi: 10.1055/s-2006-942346 pubmed: 20011312 pmcid: 2780106
Broccard SP, Colibaseanu DT, Behm KT et al (2022) Risk of malignancy and outcomes of surgically resected presacral tailgut cysts: a current review of the Mayo Clinic experience. Colorectal Dis 24:422–427. https://doi.org/10.1111/codi.16030
doi: 10.1111/codi.16030 pubmed: 34941020
Aflalo-Hazan V, Rousset P, Mourra N, Lewin M, Azizi L, Hoeffel C (2008) Tailgut cysts: MRI findings. Eur Radiol 18:2586–2593. https://doi.org/10.1007/s00330-008-1028-4
doi: 10.1007/s00330-008-1028-4 pubmed: 18566821
Gong J, Xu Y, Zhang Y, Qiao L, Xu H, Zhu P, Yang B (2022) Primary malignant tumours and malignant transformation of cysts in the retrorectal space: MRI diagnosis and treatment outcomes. Gastroenterol Rep (Oxf) 10:goac048. https://doi.org/10.1093/gastro/goac048
doi: 10.1093/gastro/goac048 pubmed: 36157328
Merchea A, Larson DW, Hubner M, Wenger DE, Rose PS, Dozois EJ (2013) The value of preoperative biopsy in the management of solid presacral tumors. Dis Colon Rectum 56:756–760. https://doi.org/10.1097/DCR.0b013e3182788c77
doi: 10.1097/DCR.0b013e3182788c77 pubmed: 23652750
Clavien PA, Barkun J, de Oliveira et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
doi: 10.1097/SLA.0b013e3181b13ca2 pubmed: 19638912
Mualem W, Ghaith AK, Rush D et al (2022) Surgical management of sacral schwannomas: a 21-year mayo clinic experience and comparative literature analysis. J Neurooncol 159:1–14. https://doi.org/10.1007/s11060-022-03986-w
doi: 10.1007/s11060-022-03986-w pubmed: 35752722
Zhao X, Zhou S, Liu N, Li P, Chen L (2022) Is there another posterior Approach for Presacral Tumors besides the Kraske Procedure? - a study on the feasibility and safety of Surgical Resection of primary presacral tumors via Transsacrococcygeal Transverse Incision. Front Oncol 12:892027. https://doi.org/10.3389/fonc.2022.892027
doi: 10.3389/fonc.2022.892027 pubmed: 35692749 pmcid: 9179022
Burke JR, Shetty K, Thomas O, Kowal M, Quyn A, Sagar P (2022) The management of retrorectal tumours: tertiary centre retrospective study. BJS Open 6:zrac044. https://doi.org/10.1093/bjsopen/zrac044
doi: 10.1093/bjsopen/zrac044 pubmed: 35441209 pmcid: 9019068
Aubert M, Mege D, Parc Y et al (2021) Surgical Management of Retrorectal tumors: a French Multicentric experience of 270 consecutives cases. Ann Surg 274:766–772. https://doi.org/10.1097/SLA.0000000000005119
doi: 10.1097/SLA.0000000000005119 pubmed: 34334645
Gould LE, Pring ET, Corr A et al (2021) Evolution of the management of retrorectal masses: a retrospective cohort study. Colorectal Dis 23:2988–2998. https://doi.org/10.1111/codi.15893
doi: 10.1111/codi.15893 pubmed: 34459085
Zhang D, Sun Y, Lian L et al (2021) Long-term surgical outcomes after resection of presacral tumours and risk factors associated with recurrence. Colorectal Dis 23:2301–2310. https://doi.org/10.1111/codi.15691
doi: 10.1111/codi.15691 pubmed: 33900009
Li Z, Lu M (2021) Presacral Tumor: insights from a Decade’s experience of this rare and diverse disease. Front Oncol 11:639028. https://doi.org/10.3389/fonc.2021.639028
doi: 10.3389/fonc.2021.639028 pubmed: 33796466 pmcid: 8008122
Carpelan-Holmström M, Koskenvuo L, Haapamäki C, Renkonen-Sinisalo L, Lepistö A (2020) Clinical management of 52 consecutive retro-rectal tumours treated at a tertiary referral centre. Colorectal Dis 22:1279–1285. https://doi.org/10.1111/codi.15080
doi: 10.1111/codi.15080 pubmed: 32336000
Yalav O, Topal U, Eray İC, Deveci MA, Gencel E, Rencuzogullari A (2020) Retrorectal tumor: a single-center 10-years’ experience. Ann Surg Treat Res 99:110–117. https://doi.org/10.4174/astr.2020.99.2.110
doi: 10.4174/astr.2020.99.2.110 pubmed: 32802816 pmcid: 7406398
Houdek MT, Hevesi M, Griffin AM et al (2020) Can the ACS-NSQIP surgical risk calculator predict postoperative complications in patients undergoing sacral tumor resection for chordoma? J Surg Oncol 121:1036–1041. https://doi.org/10.1002/jso.25865
doi: 10.1002/jso.25865 pubmed: 32034772
Zhou J, Zhao B, Qiu H et al (2020) Laparoscopic resection of large retrorectal developmental cysts in adults: single-centre experiences of 20 cases. J Minim Access Surg 16:152–159. https://doi.org/10.4103/jmas.JMAS_214_18
doi: 10.4103/jmas.JMAS_214_18 pubmed: 30416141 pmcid: 7176010
Sakr A, Kim HS, Han YD et al (2019) Single-center experience of 24 cases of Tailgut Cyst. Ann Coloproctol 35:268–274. https://doi.org/10.3393/ac.2018.12.18
doi: 10.3393/ac.2018.12.18 pubmed: 31726003 pmcid: 6863012
Poškus E, Račkauskas R, Danys D, Valančienė D, Poškus T, Strupas K (2019) Does a retrorectal tumour remain a challenge for surgeons? Acta Chir Belg 119:289–293. https://doi.org/10.1080/00015458.2018.1515397
doi: 10.1080/00015458.2018.1515397 pubmed: 30270764
Dziki Ł, Włodarczyk M, Sobolewska-Włodarczyk A et al (2019) Presacral tumors: diagnosis and treatment - a challenge for a surgeon. Arch Med Sci 15:722–729. https://doi.org/10.5114/aoms.2016.61441
doi: 10.5114/aoms.2016.61441 pubmed: 31110540
Dwarkasing RS, Verschuuren SI, van Leenders GJLH, Braun LMM, Krestin GP, Schouten WR (2017) Primary cystic lesions of the Retrorectal Space: MRI evaluation and clinical Assessment. AJR Am J Roentgenol 209:790–796. https://doi.org/10.2214/AJR.16.17329
doi: 10.2214/AJR.16.17329 pubmed: 28705066
Maddah G, Abdollahi A, Etemadrezaie H, Ganjeifar B, Gohari B, Abdollahi M, Hassanpour M (2016) Problems in diagnosis and treatment of Retrorectal tumors: our experience in 50 patients. Acta Med Iran 54:644–650
pubmed: 27888592
Buchs NC, Gosselink MP, Scarpa CR et al (2016) A multicenter experience with peri-rectal tumors: the risk of local recurrence. Eur J Surg Oncol 42:817–822. https://doi.org/10.1016/j.ejso.2016.02.018
doi: 10.1016/j.ejso.2016.02.018 pubmed: 26972375
Sun W, Ma XJ, Zhang F, Miao WL, Wang CR, Cai ZD (2016) Surgical Treatment of Sacral Neurogenic Tumor: a 10-year experience with 64 cases. Orthop Surg 8:162–170. https://doi.org/10.1111/os.12245
doi: 10.1111/os.12245 pubmed: 27384724 pmcid: 6584081
Hopper L, Eglinton TW, Wakeman C, Dobbs BR, Dixon L, Frizelle FA (2016) Progress in the management of retrorectal tumours. Colorectal Dis 18:410–417. https://doi.org/10.1111/codi.13117
doi: 10.1111/codi.13117 pubmed: 26367385
Gong L, Liu W, Li P, Huang X (2015) Transsacrococcygeal approach for resection of retrorectal tumors. Am Surg 81:569–572
doi: 10.1177/000313481508100619 pubmed: 26031268
Simpson PJ, Wise KB, Merchea A, Cheville JC, Moir C, Larson DW, Dozois EJ (2014) Surgical outcomes in adults with benign and malignant sacrococcygeal teratoma: a single-institution experience of 26 cases. Dis Colon Rectum 57:851–857. https://doi.org/10.1097/DCR.0000000000000117
doi: 10.1097/DCR.0000000000000117 pubmed: 24901686
Sagar AJ, Koshy A, Hyland R, Rotimi O, Sagar PM (2014) Preoperative assessment of retrorectal tumours. Br J Surg 101:573–577. https://doi.org/10.1002/bjs.9413
doi: 10.1002/bjs.9413 pubmed: 24633832
Messick CA, Hull T, Rosselli G, Kiran RP (2013) Lesions originating within the retrorectal space: a diverse group requiring individualized evaluation and surgery. J Gastrointest Surg 17:2143–2152. https://doi.org/10.1007/s11605-013-2350-y
doi: 10.1007/s11605-013-2350-y pubmed: 24146338
Chéreau N, Lefevre JH, Meurette G, Mourra N, Shields C, Parc Y, Tiret E (2013) Surgical resection of retrorectal tumours in adults: long-term results in 47 patients. Colorectal Dis 15:e476–e482. https://doi.org/10.1111/codi.12255
doi: 10.1111/codi.12255 pubmed: 23601092
Macafee DA, Sagar PM, El-Khoury T, Hyland R (2012) Retrorectal tumours: optimization of surgical approach and outcome. Colorectal Dis 14:1411–1417. https://doi.org/10.1111/j.1463-1318.2012.02994.x
doi: 10.1111/j.1463-1318.2012.02994.x pubmed: 22339762
Du F, Jin K, Hu X, Dong X, Cao F (2012) Surgical treatment of retrorectal tumors: a retrospective study of a ten-year experience in three institutions. Hepatogastroenterology 59:1374–1377. https://doi.org/10.5754/hge11686
doi: 10.5754/hge11686 pubmed: 22366467
Li GD, Chen K, Fu D, Ma XJ, Sun MX, Sun W, Cai ZD (2011) Surgical strategy for presacral tumors: analysis of 33 cases. Chin Med J (Engl) 124:4086–4091
pubmed: 22340347
Lin C, Jin K, Lan H, Teng L, Lin J, Chen W (2011) Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institution. Onco Targets Ther 4:203–208. https://doi.org/10.2147/OTT.S25271
doi: 10.2147/OTT.S25271 pubmed: 22162926 pmcid: 3233279
Gao XH, Zhang W, Fu CG, Liu LJ, Yu ED, Meng RG (2011) Local recurrence after intended curative excision of presacral lesions: causes and preventions. World J Surg 35:2134–2142. https://doi.org/10.1007/s00268-011-1155-y
doi: 10.1007/s00268-011-1155-y pubmed: 21607819
Dozois EJ, Jacofsky DJ, Billings BJ et al (2011) Surgical approach and oncologic outcomes following multidisciplinary management of retrorectal sarcomas. Ann Surg Oncol 18:983–988. https://doi.org/10.1245/s10434-010-1445-x
doi: 10.1245/s10434-010-1445-x pubmed: 21153886
Yang BL, Gu YF, Shao WJ, Chen HJ, Sun GD, Jin HY, Zhu X (2010) Retrorectal tumors in adults: magnetic resonance imaging findings. World J Gastroenterol 16:5822–5829. https://doi.org/10.3748/wjg.v16.i46.5822
doi: 10.3748/wjg.v16.i46.5822 pubmed: 21155003 pmcid: 3001973
Mathis KL, Dozois EJ, Grewal MS, Metzger P, Larson DW, Devine RM (2010) Malignant risk and surgical outcomes of presacral tailgut cysts. Br J Surg 97:575–579. https://doi.org/10.1002/bjs.6915
doi: 10.1002/bjs.6915 pubmed: 20169572
Wei G, Xiaodong T, Yi Y, Ji T (2009) Strategy of surgical treatment of sacral neurogenic tumors. Spine (Phila Pa 1976) 34:2587–2592. https://doi.org/10.1097/BRS.0b013e3181bd4a2b
doi: 10.1097/BRS.0b013e3181bd4a2b pubmed: 19927109
Pappalardo G, Frattaroli FM, Casciani E et al (2009) Retrorectal tumors: the choice of surgical approach based on a new classification. Am Surg 75:240–248
doi: 10.1177/000313480907500311 pubmed: 19350861
Grandjean JP, Mantion GA, Guinier D et al (2008) Vestigial retrorectal cystic tumors in adults: a review of 30 cases. Gastroenterol Clin Biol 32:769–778. https://doi.org/10.1016/j.gcb.2008.03.011
doi: 10.1016/j.gcb.2008.03.011 pubmed: 18485646
Woodfield JC, Chalmers AG, Phillips N, Sagar PM (2008) Algorithms for the surgical management of retrorectal tumours. Br J Surg 95:214–221. https://doi.org/10.1002/bjs.5931
doi: 10.1002/bjs.5931 pubmed: 17933000
Glasgow SC, Birnbaum EH, Lowney JK et al (2005) Retrorectal tumors: a diagnostic and therapeutic challenge. Dis Colon Rectum 48:1581–1587. https://doi.org/10.1007/s10350-005-0048-2
doi: 10.1007/s10350-005-0048-2 pubmed: 15937630
Lev-Chelouche D, Gutman M, Goldman G et al (2003) Presacral tumors: a practical classification and treatment of a unique and heterogeneous group of diseases. Surgery 133:473–478. https://doi.org/10.1067/msy.2003.118
doi: 10.1067/msy.2003.118 pubmed: 12773974
Baek SK, Hwang GS, Vinci A, Jafari MD, Jafari F, Moghadamyeghaneh Z, Pigazzi A (2016) Retrorectal tumors: a Comprehensive Literature Review. World J Surg 40:2001–2015. https://doi.org/10.1007/s00268-016-3501-6
doi: 10.1007/s00268-016-3501-6 pubmed: 27083451
Toh JW, Morgan M (2016) Management approach and surgical strategies for retrorectal tumours: a systematic review. Colorectal Dis 18:337–350. https://doi.org/10.1111/codi.13232
doi: 10.1111/codi.13232 pubmed: 26663419
Brown IS, Sokolova A, Rosty C, Graham RP (2023) Cystic lesions of the retrorectal space. Histopathology 82:232–241. https://doi.org/10.1111/his.14769
doi: 10.1111/his.14769 pubmed: 35962741
Wang YS, Guo QY, Zheng FH et al (2022) Retrorectal mucinous adenocarcinoma arising from a tailgut cyst: a case report and review of literature. World J Gastrointest Surg 14:1072–1081. https://doi.org/10.4240/wjgs.v14.i9.1072
doi: 10.4240/wjgs.v14.i9.1072 pubmed: 36185552 pmcid: 9521465
Nicoll K, Bartrop C, Walsh S, Foster R, Duncan G, Payne C, Carden C (2019) Malignant transformation of tailgut cysts is significantly higher than previously reported: systematic review of cases in the literature. Colorectal Dis 21:869–878. https://doi.org/10.1111/codi.14628
doi: 10.1111/codi.14628 pubmed: 30932326
Waisman M, Kligman M, Roffman M (1997) Posterior approach for radical excision of sacral chordoma. Int Orthop 21:181–184. https://doi.org/10.1007/s002640050146
doi: 10.1007/s002640050146 pubmed: 9266299 pmcid: 3617677
Pennington Z, Reinshagen C, Ahmed AK, Barber S, Goodwin ML, Gokaslan Z, Sciubba DM (2019) Management of presacral schwannomas-a 10-year multi-institutional series. Ann Transl Med 7:228. https://doi.org/10.21037/atm.2019.01.66
doi: 10.21037/atm.2019.01.66 pubmed: 31297393 pmcid: 6595202
Dozois EJ, Marcos MDH (2011) Presacral tumors, in The ASCRS textbook of colon and rectal surgery. Springer, pp 359–374 60
Dozois E, Jacofsky D, Dozois R (2007) The ASCRS textbook of colon and rectal surgery. Springer, New York, pp 501–514
Kraske P (1886) Zur Exstirpation Hochsitzender Mastdarmkrebse. Arch Klin Chir 33:563–573

Auteurs

K Fechner (K)

Department of Surgery, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Krankenhausstraße 12, D-91054, Erlangen, Germany. katja.fechner@uk-erlangen.de.

B Bittorf (B)

Department of Surgery, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Krankenhausstraße 12, D-91054, Erlangen, Germany.

M Langheinrich (M)

Department of General, Thoracic and Vascular Surgery, Greifswald University, Ferdinand-Sauerbruch-Straße, Greifswald, Germany.

K Weber (K)

Department of Surgery, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Krankenhausstraße 12, D-91054, Erlangen, Germany.

M Brunner (M)

Department of Surgery, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Krankenhausstraße 12, D-91054, Erlangen, Germany.

R Grützmann (R)

Department of Surgery, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Krankenhausstraße 12, D-91054, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Comprehensive Cancer Center Alliance WERA (CCC WERA), Erlangen, Germany.
Bavarian Cancer Research Center (BZKF), Erlangen, Germany.

K E Matzel (KE)

Department of Surgery, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Krankenhausstraße 12, D-91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH